Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Elizabeth S Borden"'
Autor:
Anngela C Adams, Anne M Macy, Elizabeth S Borden, Lauren M Herrmann, Kenneth H Buetow, Melissa A Wilson, Denise J Roe, Karen Taraszka Hastings
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/b48d5a534d944f9a9ed7109d1b1ca8bc
Autor:
Anngela C Adams, Anne M Macy, Elizabeth S Borden, Kenneth H Buetow, Melissa A Wilson, Denise J Roe, Karen Taraszka Hastings, Tiffany Y Juan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/cf965a71dff04ae690d80478f506ce02
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Prioritization of immunogenic neoantigens is key to enhancing cancer immunotherapy through the development of personalized vaccines, adoptive T cell therapy, and the prediction of response to immune checkpoint inhibition. Neoantigens are tumor-specif
Externí odkaz:
https://doaj.org/article/91864b7292aa41c28ed648c9dc9320b2
Autor:
Elizabeth S. Borden, Paul Kang, Heini M. Natri, Tanya N. Phung, Melissa A. Wilson, Kenneth H. Buetow, Karen Taraszka Hastings
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
A low percentage of actinic keratoses progress to develop into cutaneous squamous cell carcinoma. The immune mechanisms that successfully control or eliminate the majority of actinic keratoses and the mechanisms of immune escape by invasive squamous
Externí odkaz:
https://doaj.org/article/290841e50e864303beb9d5cdf10c95a6
Autor:
Anngela C. Adams, Elizabeth S. Borden, Anne M. Macy, Nick Thomson, Haiyan Cui, Mark I. Gimbel, Melissa A. Wilson, Kenneth H. Buetow, Denise J. Roe, David J. DiCaudo, Jade Homsi, Karen Taraszka Hastings
Publikováno v:
Cancers; Volume 14; Issue 9; Pages: 2200
Gamma-interferon-inducible lysosomal thiol reductase (GILT) is critical for MHC class II restricted presentation of multiple melanoma antigens. There is variable GILT protein expression in malignant melanocytes in melanoma specimens. High GILT mRNA e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4983515d3ebe50b95675f7040c95e10
Autor:
Elizabeth S. Borden, Suhail Ghafoor, Kenneth H. Buetow, Bonnie J. LaFleur, Melissa A. Wilson, K. Taraszka Hastings
Publikováno v:
J Immunol
Accurate prioritization of immunogenic neoantigens is key to developing personalized cancer vaccines and distinguishing those patients likely to respond to immune checkpoint inhibition. However, there is no consensus regarding which characteristics b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::411a8fd6592b4610803f6c706c2ca852
https://europepmc.org/articles/PMC8983234/
https://europepmc.org/articles/PMC8983234/
Autor:
Elizabeth S. Borden, Anngela C. Adams, Kenneth H. Buetow, Melissa A. Wilson, Julie E. Bauman, Clara Curiel-Lewandrowski, H.-H. Sherry Chow, Bonnie J. LaFleur, Karen Taraszka Hastings
Publikováno v:
Cancers; Volume 14; Issue 1; Pages: 3
Cancers, Vol 14, Iss 3, p 3 (2022)
Cancers
Cancers, Vol 14, Iss 3, p 3 (2022)
Cancers
Simple Summary Melanoma is a deadly skin cancer, and the incidence of melanoma is rising. Chemoprevention, using small molecule drugs to prevent the development of cancer, is a key strategy that could reduce the burden of melanoma on society. The lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::294fe39a9929758936435d36e9e484c2
Autor:
Elizabeth S. Borden, Anngela C. Adams, Kenneth H. Buetow, Melissa A. Wilson, Julie E. Bauman, Clara Curiel-Lewandrowski, H.-H. Sherry Chow, Bonnie J. LaFleur, Karen Taraszka Hastings
Publikováno v:
Cancer Prevention Research. 15:A006-A006
There is a need to identify biomarkers of melanoma progression to assist the development of chemoprevention strategies to lower melanoma incidence. In this study, we assessed the feasibility of creating a molecular signature for melanomagenesis using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d284b5078ddd1992a400ff543346007
https://doi.org/10.1158/1940-6215.tacpad22-a006
https://doi.org/10.1158/1940-6215.tacpad22-a006
Autor:
Elizabeth S Borden, Tanya N Phung, Kenneth H Buetow, Bonnie Lafleur, Melissa A Wilson, Karen Taraszka Hastings
Publikováno v:
The Journal of Immunology. 206:104.08-104.08
Current approaches to prioritization of tumor-specific neoantigens have low sensitivity and specificity, directly impacting the development of personalized vaccines and the prediction of immunotherapy efficacy. Many biological features have been sugg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe7630eae659d5d334eb321302bd2c78
https://doi.org/10.4049/jimmunol.206.supp.104.08
https://doi.org/10.4049/jimmunol.206.supp.104.08
HCV- and HBV-mediated liver cancer converge on similar transcriptomic landscapes and immune profiles
Autor:
Elizabeth S. Borden, Annika Jorgensen, Heini M. Natri, Karen Taraszka Hastings, Kenneth H. Buetow, Melissa A. Wilson
Publikováno v:
HGG Advances, Vol 6, Iss 1, Pp 100373- (2025)
Summary: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related deaths worldwide, and a large proportion is attributable to viral causes, including hepatitis B (HBV) and C viruses (HCV). The pathogenesis of viral-mediated HCC can di
Externí odkaz:
https://doaj.org/article/389fea86455744f098c49048df66e441